Wells Fargo Reaffirms Their Buy Rating on Agilent (A)
Wells Fargo analyst Brandon Couillard maintained a Buy rating on Agilent yesterday and set a price target of $175.00.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Couillard covers the Healthcare sector, focusing on stocks such as Agilent, Exact Sciences, and Bio-Rad Laboratories. According to TipRanks, Couillard has an average return of 17.2% and a 62.62% success rate on recommended stocks.
In addition to Wells Fargo, Agilent also received a Buy from UBS’s Dan Leonard in a report issued yesterday. However, on the same day, Barclays maintained a Hold rating on Agilent (NYSE: A).
Based on Agilent’s latest earnings release for the quarter ending July 31, the company reported a quarterly revenue of $1.74 billion and a net profit of $336 million. In comparison, last year the company earned a revenue of $1.58 billion and had a net profit of $282 million
Read More on A:
Disclaimer & DisclosureReport an Issue
- Agilent Technologies Reports Strong Q4 Earnings Amid Challenges
- Agilent price target raised to $170 from $162 at TD Cowen
- Agilent price target raised to $180 from $170 at UBS
- Agilent’s Strong Organic Growth and Strategic Positioning Justify Buy Rating and Raised Price Target
- Agilent price target raised to $165 from $142 at Baird
